Skip to main content
Livermore
Livermore
ZHEN

Ellevest, Inc.

SEC CIK
0001644128
Latest filing
Aug 10, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Ellevest, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
1,534
Value
$752.2K
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of VRTX by Ellevest, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,534$752.2K0.1%+92+6.4%AddedHolders
Q1 20261,442$643.9K0.1%+561+63.7%AddedHolders
Q4 2025881$399.4K0.1%−18−2.0%ReducedHolders
Q3 2025899$352.1K0.1%+22+2.5%AddedHolders
Q2 2025877$390.4K0.1%−231−20.8%ReducedHolders
Q1 20251,108$537.2K<0.1%−546−33.0%ReducedHolders
Q4 20241,654$666.1K<0.1%−107−6.1%ReducedHolders
Q3 20241,761$819.0K<0.1%+14+0.8%AddedHolders
Q2 20241,747$818.9K<0.1%+65+3.9%AddedHolders
Q1 20241,682$703.1K<0.1%−7−0.4%ReducedHolders
Q4 20231,689$687.2K<0.1%−121−6.7%ReducedHolders
Q3 20231,810$629.4K<0.1%+232+14.7%AddedHolders
Q2 20231,578$555.3K<0.1%+117+8.0%AddedHolders
Q1 20231,461$460.3K<0.1%+265+22.2%AddedHolders
Q4 20221,196$345.4K<0.1%+103+9.4%AddedHolders
Q3 20221,093$316.0K<0.1%+235+27.4%AddedHolders
Q2 2022858$242.0K<0.1%+645+302.8%AddedHolders
Q1 2022213$56.0K<0.1%−41−16.1%ReducedHolders
Q4 2021254$56.0K<0.1%−1,132−81.7%ReducedHolders
Q3 20211,386$251.0K<0.1%−71−4.9%ReducedHolders
Q2 20211,457$294.0K<0.1%+271+22.8%AddedHolders
Q1 20211,186$255.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.